MarketPulse
D

$DAWN

4 articles found
3 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

XOMA Royalty Surges on 68% Royalty Growth and Aggressive Portfolio Expansion

XOMA Royalty reports $50M+ cash receipts in 2025, with royalties up 68% YoY. Company adds 22 assets, completes seven acquisitions, and repurchases $16M in shares.
DAWNRZLTGOSSZVRAMIRM+3acquisitionsshare buyback
GlobeNewswire Inc.GlobeNewswire Inc.··Halper Sadeh Llc

Law Firm Probes Four Companies Over Fair-Deal Concerns in Major Transactions

Law firm investigates four companies for potential fiduciary duty breaches in proposed sales, examining insider conflicts and restrictive deal structures.
EWCZDAWNFONRSEMshareholder rightsfiduciary duty
BenzingaBenzinga··Globe Newswire

Servier Acquires Day One Biopharmaceuticals for $2.5B to Bolster Rare Oncology Pipeline

Servier acquires Day One Biopharmaceuticals for $2.5B in cash, expanding rare pediatric oncology portfolio with closing expected Q2 2026.
DAWNacquisitionbiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Day One Biopharmaceuticals Posts 172% Revenue Growth on OJEMDA Sales Strength

Day One Biopharmaceuticals reports 172% revenue growth to $155.4M, driven by OJEMDA sales strength. Company acquires Mersana Therapeutics to expand pipeline.
DAWNclinical trialsrevenue growth